Lawal Jamila, Dadi Hassan Iliya, Sanni Rasheedat, Shofoluwe Nurudeen Adebola
Consultant Otorhinolaryngologist/Lecture Ear, Nose and Throat Unit, Department of Surgery Barau Dikko Teaching Hospital and Kaduna State University, Kaduna, Nigeria.
Department of Clinical Services, National Ear Care Centre, Kaduna, Nigeria.
J West Afr Coll Surg. 2021 Jan-Mar;11(1):23-28. doi: 10.4103/jwas.jwas_61_22. Epub 2022 Jun 22.
Remnants or the regrowth of adenoid tissue after adenoidectomy may present with clinical symptoms that could warrant a revision surgery.
This study aims to determine the prevalence and risk factors of revision adenoidectomy in our centre.
This is a retrospective case-control study conducted in a tertiary otorhinolaryngology centre over a 10-year period. Cases of revision adenoidectomies were identified and matched with controlled cases of single-stage adenoidectomies within the same period. All information was entered into the Statistical Package for the Social Sciences (SPSS) version 25 and analysed using descriptive and cross-tabulation analysis.
A total of 1249 adenoidectomies were performed during the period of review with 26 being revision cases. The prevalence of revision adenoidectomy was found to be 2.1% with the mean interval between surgeries being 2.1 years. Age ≤ 2 years (odds ratio (OR) = 95.25, < 0.0001), allergy (OR = 0.09, < 0.0001), recurrent tonsillitis (OR = 0.79, = 0.006), recurrent/chronic middle ear infections (OR = 7.5, < 0.0001), and the primary surgeon being a junior registrar (OR = 11.5, < 0.0001) were significantly associated with revision adenoidectomy. The performance of adenoidectomy without tonsillectomy also carries a significant odd ( = 0.04).
Revision adenoidectomy is low in our setting. Young age at primary surgery, the presence of allergy, surgeon's designation, the extent of surgery, and recurrent middle ear and tonsil infections are factors associated with revision adenoidectomy. These should be considered in risk stratification and surgery planning.
腺样体切除术后腺样体组织残留或再生可能会出现需要再次手术的临床症状。
本研究旨在确定我院再次腺样体切除术的发生率及危险因素。
这是一项在三级耳鼻喉科中心进行的为期10年的回顾性病例对照研究。确定再次腺样体切除术病例,并与同期单阶段腺样体切除术的对照病例进行匹配。所有信息录入社会科学统计软件包(SPSS)25版,采用描述性分析和交叉表分析。
在研究期间共进行了1249例腺样体切除术,其中26例为再次手术病例。再次腺样体切除术的发生率为2.1%,两次手术的平均间隔时间为2.1年。年龄≤2岁(比值比(OR)=95.25,P<0.0001)、过敏(OR = 0.09,P<0.0001)、复发性扁桃体炎(OR = 0.79,P = 0.006)、复发性/慢性中耳感染(OR = 7.5,P<0.0001)以及主刀医生为初级住院医师(OR = 11.5,P<0.0001)与再次腺样体切除术显著相关。单纯行腺样体切除术也有显著差异(P = 0.04)。
我院再次腺样体切除术发生率较低。初次手术年龄小、存在过敏、医生职称、手术范围以及复发性中耳和扁桃体感染是与再次腺样体切除术相关的因素。在风险分层和手术规划中应考虑这些因素。